These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Cold storage of citrated whole blood induces drastic time-dependent losses in factor VIII and von Willebrand factor: potential for misdiagnosis of haemophilia and von Willebrand disease. Böhm M; Täschner S; Kretzschmar E; Gerlach R; Favaloro EJ; Scharrer I Blood Coagul Fibrinolysis; 2006 Jan; 17(1):39-45. PubMed ID: 16607078 [TBL] [Abstract][Full Text] [Related]
44. [Production of factor VIII preparations and their use in the substitution therapy of hemophilia A]. Gaerisch F; Stein P Z Gesamte Inn Med; 1982 Oct; 37(19):641-4. PubMed ID: 6817530 [TBL] [Abstract][Full Text] [Related]
45. [Study on capillary blood of blood coagulation in the newborn at term and in infants]. Alexandre P; Andre E; Streiff F Arch Fr Pediatr; 1974 Oct; 31(8):739-49. PubMed ID: 4462494 [No Abstract] [Full Text] [Related]
47. [The status of blood coagulation preparations within the scope of modern hemotherapy in surgical patients]. Kretschmer V Beitr Infusionsther; 1989; 24():134-50. PubMed ID: 2481530 [TBL] [Abstract][Full Text] [Related]
48. Use of blood products and factor concentrates for coagulation therapy. Fritsma MG Clin Lab Sci; 2003; 16(2):115-9. PubMed ID: 12757192 [TBL] [Abstract][Full Text] [Related]
49. [Precision control of a single step determination of blood coagulation factor VIII in the plasma]. Lutze G Folia Haematol Int Mag Klin Morphol Blutforsch; 1977; 104(1):109-15. PubMed ID: 69567 [TBL] [Abstract][Full Text] [Related]
50. Preservation of coagulation factors V and VIII during collection and subsequent storage of bank blood in ACD-A and CPD solutions. Weisert O; Jeremic M Vox Sang; 1973 Feb; 24(2):126-33. PubMed ID: 4682805 [No Abstract] [Full Text] [Related]
51. A study of changes in platelets, antihaemophilic globulin, factor V and factor VII during blood collection and storage by different techniques. MUSTARD JF Br J Haematol; 1957 Apr; 3(2):202-14. PubMed ID: 13413107 [No Abstract] [Full Text] [Related]
52. The response of an acquired Factor V inhibitor to activated Factor IX concentrate. Vickars LM; Coupland RW; Naiman SC Transfusion; 1985; 25(1):51-3. PubMed ID: 3871542 [TBL] [Abstract][Full Text] [Related]
53. Prevention and treatment of coagulopathy in patients receiving massive transfusions. Levi M; Fries D; Gombotz H; van der Linden P; Nascimento B; Callum JL; Bélisle S; Rizoli S; Hardy JF; Johansson PI; Samama CM; Grottke O; Rossaint R; Henny CP; Goslings JC; Theusinger OM; Spahn DR; Ganter MT; Hess JR; Dutton RP; Scalea TM; Levy JH; Spinella PC; Panzer S; Reesink HW Vox Sang; 2011 Aug; 101(2):154-74. PubMed ID: 21749403 [No Abstract] [Full Text] [Related]
54. Blood and blood components in the prevention and control of bleeding. Schmidt PJ; Grindon AJ JAMA; 1967 Dec; 202(10):967-9. PubMed ID: 5630741 [No Abstract] [Full Text] [Related]
55. Fresh whole blood use for hemorrhagic shock: preserving benefit while avoiding complications. Spinella PC; Reddy HL; Jaffe JS; Cap AP; Goodrich RP Anesth Analg; 2012 Oct; 115(4):751-8. PubMed ID: 22763908 [TBL] [Abstract][Full Text] [Related]
56. [Clinical problems connected with massive transfusion of stored blood]. Osowski L; Kłos M Wiad Lek; 1978 Apr; 31(8):527-13. PubMed ID: 27014 [No Abstract] [Full Text] [Related]
57. Blood-component therapy. Garrell M; Hill WO; Westphal R Ann Intern Med; 1972 Sep; 77(3):484-5. PubMed ID: 5077787 [No Abstract] [Full Text] [Related]
58. The use of fresh blood to correct coagulation defects associated with trauma and shock. Kovaric JJ; Hamit HF Mil Med; 1968 Jul; 133(7):534-7. PubMed ID: 4977075 [No Abstract] [Full Text] [Related]
59. [Therapeutic problems after massive blood transfusions]. Wendt M; Lawin P; Götz E Infusionsther Klin Ernahr; 1979 Dec; 6(6):325-9. PubMed ID: 396253 [TBL] [Abstract][Full Text] [Related]